Plegridy
| Chemical Name | peginterferon beta-1a |
| Dosage Form | Injection (subcutaneous; 125mg/0.5mL, 63mg/0.5mL, 94mg/0.5mL) |
| Drug Class | Modulators |
| System | Blood |
| Company | Biogen |
| Approval Year | 2014 |
Indication
- For the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.